Clozapine for treatment-refractory mania

American Journal of Psychiatry

Volumn 153, Issue 6, 1996, Pages 759-764

  Calabrese, Joseph R ^a,b   Kimmel, Susan E ^a   Woyshville, Mark J ^a   Rapport, Daniel J ^a   Faust, Carl J ^a   Thompson, Paul A ^a   Meltzer, Herbert Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORAL HYDRATE; CLONAZEPAM; CLOZAPINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; NORTRIPTYLINE; SERTRALINE; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPERSALIVATION; INSOMNIA; LITHIUM BLOOD LEVEL; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RECORD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCHIZOIDISM;

EID: 0029973013     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.6.759     Document Type: Article

References (29)

1. Dunner DL, Fieve RR: Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30:229-233
2. Kukopolos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L: Course of the manic depressive cycle and changes caused by treatment. Pharmacopsychiatria 1980; 13:156-167
3. Davis KL, Berger PA, Hollister LE: Tardive dyskinesia and depressive illness. Psychopharmacology Communications 1976; 2: 125-130
4. Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD, Small IF: Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48:915-921
5. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ: Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993; 13:280-283
6. Meltzer HY: Dimensions of outcome with clozapine. Br J Psychiatry 1992; 160:46-53
7. Nahunek K, Svestka J, Misurec J, Rodova D: [Experiences with clozapine.] Cesk Psychiatr 1975; 71:11-21 (Czech)
8. Klik J, Kraausova J, Krizova K, Maresova H, Vencovsky E: [Experience with clozapine in psychiatric home practice.] Cesk Psychiatr 1976; 72:197-200 (Czech)
9. Muller P, Heipertz R: [Treatment of manic psychosis with clozapine.] Fortschr Neurol Psychiatr 1977; 45:420-424 (German)
10. Naber D, Hippius H: The European experience with use of clozapine. Hosp Community Psychiatry 1990; 41:886-890
11. McElroy SL, Dessain EC, Pope HG, Cole JO, Keck PE, Frankenberg FR, Aizley HG, O'Brien S: Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991; 52:411-414
12. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO: Clozapine in the treatment of dysphoric manic. Biol Psychiatry 1992; 32:270-280
13. Cole JO, Zarate CA, Banov MD, Green AI: Clozapine in affective disorders (abstract), in Proceedings of the 1993 Annual Meeting of the American College of Neuropsychopharmacology. Nashville, ACNP, 1993, p 69
14. Calabrese JR, Meltzer HY, Markovitz PJ: Clozapine prophylaxis in rapid-cycling bipolar disorder. J Clin Psychopharmacol 1991; 11:396-397
15. Kogan W, Nikolaenko N: [New drugs in the treatment of nervous and mental disease.] Reports of Leningrad Bechterev Psychoneurological Research Institute, 1974, p 40-41 (Russian)
16. Nahunek K, Svestka J, Misurec J, Rodova D: [Experiences with clozapine.] Cesk Psychiatr 1975; 71:11-20 (Czech)
17. Parsa M, Ramirez LF, Loula EC, Meltzer HY: Effect of clozapine on psychotic depression and parkinsonism. J Clin Psychopharmacol 1991; 11:330-331
18. Dassa D, Kaladjian A, Azorin JM, Giudicelli S: Clozapine in the treatment of psychotic refractory depression. Br J Psychiatry 1993; 163:822-824
19. Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia - Change Version, 3rd ed. New York, New York State Psychiatric Institute, Biometrics Research, 1978
20. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd ed. New York, New York State Psychiatric Institute, Biometrics Research, 1978
21. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
22. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
23. Jennrich RI, Schluchter MD: Unbalanced repeated measures models with structured covariance matrices. Biometrics 1986; 42:805-820
24. SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, release 6.07. Cary, NC, SAS Institute, 1992
25. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp 534-537
26. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand (Suppl) 1970; 212:11-19
27. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD: Efficacy of divalproex vs lithium and placebo in the treatment of mania: the Depakote Mania Study Group. JAMA 1994; 271:918-924; correction, 271:1830
28. Meltzer HY, Burnett S, Bastani B, Ramirez LF: Effect of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990; 41: 892-897
29. Bauer MS, Calabrese J, Dunner DL, Post R, Whybrow PC, Gyulai L, Tay LK, Younkin SR, Bynum D, Lavori P, Price RA: Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994; 151:506-515